Schedule 13G ownership disclosure

INOTEK PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 45780V102

Event date: 2015-08-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-15-000647
Form type
SC 13G
Filer
ROCKET PHARMACEUTICALS, INC.
CIK
CIK 1281895
Filed
Aug 24, 2015
Reporting period
Aug 21, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub